Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells

BACKGROUND: Cancer stem cells (CSCs) are related to the patient’s prognosis, recurrence and therapy resistance in oesophageal squamous cell carcinoma (ESCC). Although increasing evidence suggests that aspirin (acetylsalicylic acid, ASA) could lower the incidence and improve the prognosis of ESCC, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Zhigeng, Zheng, Wei, Fan, Hongjun, Deng, Guodong, Lu, Shih-Hsin, Jiang, Wei, Yu, Xiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438052/
https://www.ncbi.nlm.nih.gov/pubmed/34316020
http://dx.doi.org/10.1038/s41416-021-01499-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438052/
https://www.ncbi.nlm.nih.gov/pubmed/34316020
http://dx.doi.org/10.1038/s41416-021-01499-3

Ejemplares similares